MedPath

Adjuvant Chemotherapy With Gemcitabine in Patients Undergoing Curative-Intent Resection of Biliary Cancer: a Phase I/II Trial

Phase 1
Conditions
Biliary Cancer
Registration Number
JPRN-UMIN000000598
Lead Sponsor
Department of Surgery Graduate School of Medicine Kyoto University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
26
Inclusion Criteria

Not provided

Exclusion Criteria

Pulmonary fibrosis or interstitial pneumonia with radiological or clinical findings Uncontrollable pleural effusion Uncontrollable diabetes mellitus or liver dysfunction With distant metastasis except lymph node metastasis With uncured other malignancies Active infection Severe major postoperative complication such as peritonitis and massive bleeding With active peptic ulcer A history of myocardial infarction within 3 months Psychiatric disorder Pregnant or breast-feeding women, Women wishing for baby

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Phase I: Safety Phase II: Feasibility
Secondary Outcome Measures
NameTimeMethod
Phase II: Safety
© Copyright 2025. All Rights Reserved by MedPath